---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-014119"
form_type: "8-K/A"
ticker: "CRBP"
cik: "0001595097"
company_name: "Corbus Pharmaceuticals Holdings, Inc."
filed_at: "2023-04-24T23:59:59+00:00"
generated_at: "2026-06-16T18:55:41.311399+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Corbus discloses COO Craig Millian's separation terms: $445,630 severance over 12 months

## Summary
- Craig Millian resigned as COO; separation date April 14, 2023; agreement signed April 24, 2023.
- Severance includes $445,630 aggregate payment over 12 months plus COBRA premium reimbursement for 12 months.
- If a Change in Control occurs within 3 months of separation, severance extends to 18 months of base salary + COBRA.
- Stock option exercise period extended to 18 months from separation date.
- Agreement includes general release, cooperation, and non-disclosure obligations.

## SEC filing metadata
- accession: 0000950170-23-014119
- form_type: 8-K/A
- ticker: CRBP
- cik: 0001595097
- company_name: Corbus Pharmaceuticals Holdings, Inc.
- filed_at: 2023-04-24T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1595097/000095017023014119/0000950170-23-014119-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1595097/000095017023014119/crbp-20230303.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-014119
- JSON: https://secwatch.observer/filing/0000950170-23-014119.json
- Plain text: https://secwatch.observer/filing/0000950170-23-014119.txt

## Key facts
- Executive change
  Craig Millian resigned as Chief Operating Officer at Corbus Pharmaceuticals Holdings, Inc..
  - Action: resigned
  - Role: Chief Operating Officer
  source text: On April 24, 2023, Mr. Millian and the Company entered into a Separation and General Release Agreement (the “Separation Agreement”) related to Mr. Millian’s resignation as Chief Operating Officer from the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1595097/000095017023014119/0000950170-23-014119-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.